PERSPECTA

News from every angle

← Back to headlines

Praxis Precision Medicines Gains Analyst Confidence for Ulixacaltamide

Praxis Precision Medicines, Inc. (PRAX) is gaining analyst confidence regarding its drug Ulixacaltamide.

19 Feb, 08:43 — 19 Feb, 08:43

PostShare